Elagolix: all 31 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• Brain and Blood Vessel Health Following Endometriosis Treatment in People With EndometriosisNot yet recruitingNCT07799246Phase 4
• Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic PainEnrolling by invitationNCT07532876Phase 4
• Role of Menopause in ThermoregulationRecruitingNCT06798571Phase 4
• An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal WomenTerminatedNCT05038878Phase 4Results posted
• Pre-IVF Treatment With a GnRH Antagonist in Women With EndometriosisCompletedNCT04173169Phase 3Results posted
• Elagolix for Fertility Enhancement Clinical TrialCompletedNCT04039204Phase 2Results posted
• Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary SyndromeCompletedNCT03951077Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT03886220Phase 4Results posted
• Cardiovascular Disease Risk in Women With EndometriosisCompletedNCT03746535Early Phase 1Results posted
• Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT03271489Phase 3Results posted
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated PainCompletedNCT03213457Phase 3Results posted
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)CompletedNCT02691494Phase 3Results posted
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT02654054Phase 3Results posted
• Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated PainCompletedNCT02143713Phase 3Results posted
• A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated PainCompletedNCT01931670Phase 3Results posted
• Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)CompletedNCT01817530Phase 2Results posted
• Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated PainCompletedNCT01760954Phase 3Results posted
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated PainCompletedNCT01620528Phase 3Results posted
• Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine FibroidsCompletedNCT01441635Phase 2Results posted
• Efficacy and Safety Study of Elagolix in Women With EndometriosisCompletedNCT00973973Phase 2Results posted
• Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in EndometriosisCompletedNCT00797225Phase 2Results posted
• An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With EndometriosisCompletedNCT00619866Phase 2Results posted
• Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of EndometriosisCompletedNCT00437658Phase 2Results posted
• Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_tempActive, not recruitingNCT06375811Phase 3
• A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated PainCompletedNCT06076486Phase 3
• A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated PainStatus unknownNCT05648669Phase 3
• Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With EndometriosisCompletedNCT04445025Early Phase 1
• Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe PainActive, not recruitingNCT04333576Phase 3
• Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual CycleStatus unknownNCT04060992Phase 4
• An Open-label Study of the Effects of Elagolix in Adult Premenopausal FemalesCompletedNCT01403038Phase 1
• Endometriosis Trial: Study of NBI-56418 in EndometriosisCompletedNCT00109512Phase 2

← Elagolix overview